Among them, Yi et al found the high expression of enhancer of zeste homolog 2 (EZH2) in ovarian cancer and its correlation with metastasis and poor patient survival, repressing TIMP2 expression via H3K27me3 and methylation. This evidence concerns the gene EZH2 and ovarian carcinoma.